G6PD: Population genetics and clinical manifestations

Blood Reviews

Volumn 10, Issue 1, 1996, Pages 45-52

  Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETANILIDE; ANTIMALARIAL AGENT; DNA; ERYTHROCYTE ENZYME; FURAZOLIDONE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; METHYLENE BLUE; NALIDIXIC ACID; NAPHTHALENE; NIRIDAZOLE; NITROFURANTOIN; PHENAZOPYRIDINE; PHENYLHYDRAZINE; PRIMAQUINE; SULFACETAMIDE; SULFAMETHOXAZOLE; SULFANILAMIDE; SULFAPYRIDINE; THIAZOLE DERIVATIVE; TOLONIUM CHLORIDE; TRINITROTOLUENE; URATE OXIDASE;

ANEMIA; DIABETIC KETOACIDOSIS; DNA POLYMORPHISM; DRUG INDUCED DISEASE; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; INFECTION; INFECTION RESISTANCE; LIVER DYSFUNCTION; MALARIA; NEWBORN JAUNDICE; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW; STRESS; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKAGE;

EID: 0029933131     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(96)90019-3     Document Type: Article

References (104)

1. Beutler E. Glucose-6-phosphate dehydrogenase deficiency and other enzyme abnormalities. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Hematology. New York: NY McGraw-Hill, 1995: 564-580.
2. Beutler E. G6PD deficiency. Blood 1994; 84: 3613-3636.
3. Vulliamy T, Beutler E, Luzzatto L. Variants of glucose-6-phosphate dehydrogenase are due to missense mutations spread throughout the coding region of the gene. Hum Mutat 1993; 2: 159-167.
4. Luzzatto L, Mehta A. Glucose 6-phosphate dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill, 1995: 3367-3398.
5. Carson PE, Flanagan CL, Ickes CH, Alving AS. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956; 124: 484-485.
6. Beutler E. The red cell: a tiny dynamo. In: Wintrobe MM, eds. Blood Pure and Eloquent. New York: McGraw-Hill, 1980: 141-168.
7. Dern RJ, Beutler E, Alving AS. The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity. J Lab Clin Med 1955; 45: 30-39.
8. Beutler E. Hemolytic Anemia in Disorders of Red Cell Metabolism. New York, NY: Plenum Press, 1978.
9. Meloni T, Forteleoni G, Porcu A. Acute hemolytic anemia in two G6PD-deficiency children with viral hepatitis. Haematologica (Pavia) 1991; 73: 397-399.
10. Sidi Y, Aderka D, Brok-Simoni F, Benajmin D, Ramot B, Pinkhas J. Viral hepatitis with extreme hyperbilirubinemia, massive hemolysis and encephalopathy in a patient with a new G 6 PD variant. Isr J Med Sci 1980; 16: 130-133.
11. Berry E, Melmed RN. Infectious hepatitis and glucose-6-phosphate dehydrogenase deficiency. Isr J Med Sci 1977; 13: 600-603.
12. Baehner RL, Nathan DG, Castle WB. Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. J Clin Invest 1971; 50: 2466-2473.
13. Clancy RM, Levartovsky D, Leszczynska-Piziak J, Yegudin J, Abramson SB. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc Natl Acad Sci USA 1994; 91: 3680-3684.
14. Burka ER, Weaver III Z, Marks PA. Clinical spectrum of hemolytic anemia associated with G 6 PD deficiency. Ann Intern Med 1966; 64: 817-825.
15. Gellady A, Greenwood RD. G-6-PD hemolytic anemia complicating diabetic ketoacidosis. J Pediatr 1972; 80: 1037-1038.
16. Shalev O, Wollner A, Menczel J. Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. BMJ 1984; 288: 179-180.
17. Shalev O, Eliakim R, Lugassy GZ, Menczel J. Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency. Acta Haematol (Basel) 1985; 74: 227-229.
18. Gibbs WN, Gray R, Lowry M. Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Jamaica. Br J Haematol 1979; 43: 263-274.
19. Brown WR, Boon WH. Hyperbilirubinemia and kernicterus in glucose-6-phosphate dehydrogenase-deficient infants in Singapore. Pediatrics 1968; 41: 1055-1062.
20. Segni G. Su due casi di ittero nucleare in neonati con difetto enzimatico eritrocitario. Minerva Pediatr 1959; 11: 1420-1426.
21. Niazi GA, Adeyokunnu A, Westwood B, Beutler E. Severe hyperbilirubinemia and kernicterus in Saudi newborns associated with G6PD Aures: a recently discovered mutant. Ann Trop Pediatr 1995; in press.
22. Meloni T, Cagnazzo G, Dore A, Cutillo S. Phenobarbital for prevention of hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient newborn infants. J Pediatr 1973; 82: 1048-1051.
23. Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology. Acta Paediatr 1994; 83 Suppl. 394: 58-76.
24. Tan KL. Glucose-6-phosphate dehydrogenase status and neonatal jaundice. Arch Dis Child 1981; 56: 874-877.
25. Boon WH. Singapore kernicterus. Singapore Med J 1980; 21: 556-567.
26. Fok T, Lau S. Glucose-6-phosphate dehydrogenase deficiency: a preventable cause of mental retardation. BMJ 1986; 292: 829.
27. Malaka-Zafiriu K, Tsiures I, Danielides B, Cassimos C. Salicylamide glucuronide formation in newborns with severe jaundice of unknown etiology and due to glucose 6 phosphate dehydrogenase deficiency in Greece. Helv Paediatr Acta 1973; 28: 323-329.
28. Milbauer B, Peled N, Svirsky S. Neonatal hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency. Isr J Med Sci 1973; 9: 1547-1552.
29. Kaplan M, Abramov A. Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy. Pediatrics 1992; 90: 401-405.
30. O'Flynn MED, Hsia DY. Serum bilirubin levels and glucose-6-phosphate dehydrogenase deficiency in newborn American negroes. J Pediatr 1963; 63: 160-161.
31. Zinkham WH. Peripheral blood and bilirubin values in normal full-term primaquine-sensitive negro infants: effect of vitamin K. Pediatrics 1963; 31: 983-995.
32. Perkins RP. The significance of glucose-6-phosphate dehydrogenase deficiency in pregnancy. Am J Obstet Gynecol 1976; 125: 215-223.
33. Lopez R, Cooperman JM. Glucose-6-phosphate dehydrogenase deficiency and hyperbilirubinemia in the newborn. Am J Dis Child 1971; 122: 66-70.
34. Washington EC, Ector W, Abboud M, Ohning B, Holden K. Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South Med J 1995; 88: 776-779.
35. Owa JA. Relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Nigeria. Acta Paediatr Scand 1989; 78: 848-852.
36. Bienzle U, Effiong C, Luzzatto L. Erythrocyte glucose 6-phosphate dehydrogenase deficiency (G6PD type A-) and neonatal jaundice. Acta Paediatr Scand 1976; 65: 701-703.
37. Capps FPA, Gilles HM, Jolly H, Worlledge SM. Glucose-6-phoshate dehydrogenase deficiency and neonatal jaundice in Nigeria. Their relation to use of prophylactic vitamin K. Lancet 1963; 2: 379-383.
38. Slusher TM, Vreman HJ, McLaren DW, Lewison LJ, Brown AK, Stevenson DK. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 1995; 126: 102-108.
39. Newton WAJ, Bass JC. Glutathione sensitive chronic non-spherocytic hemolytic anemia. Am J Dis Child 1958; 96: 501-502.
40. Baronciani L, Tricta F, Beutler E. G6PD Campinas': A deficient enzyme with a mutation at the far 3' end of the gene. Hum Mutat 1993; 2: 77-78.
41. Engstrom PF, Beutler E. G-6-PD Tripler: A unique variant associated with chronic hemolytic disease. Blood 1970; 36: 10-13.
42. Yoshida A. Hemolytic anemia and G-6-PD deficiency. Science 1973; 179: 532-537.
43. Rattazzi MC, Corash LM, Van Zanen GE, Jaffe ER, Piomelli S. G6PD deficiency and chronic hemolysis: Four new mutants - relationships between clinical syndrome and enzyme kinetics. Blood 1971; 38: 205-218.
44. Schwartz JP, Cooperberg AA, Rosenberg A. Platelet-function studies in patients with glucose-6-phosphate dehydrogenase deficiency. Br J Haematol 1974; 27: 273-280.
45. Spangenberg P, Bosia A, Arese P, Losche W, Till U. Comparative studies on human blood platelets of normal and glucose-6-phosphate-dehydrogenase-deficient donors. Acta Biol Med Ger 1982; 41: 25-31.
46. Gray GR, Naiman SC, Robinson GCF. Platelet function and G-6-PD deficiency. Lancet 1974; 1: 997.
47. Dern RJ, Glynn MF, Brewer GJ. Studies on the correlation of the genetically determined trait, glucose-6-phosphate dehydrogenase deficiency, with behavioral manifestations in schizophrenia. J Lab Clin Med 1963; 62: 319-329.
48. Baron M, Risch N, Hamburger R et al. Genetic linkage between X-chromosome markers and bipolar affective illness. Nature 1987; 326: 289-292.
49. Bowman JE, Brewer GJ, Frischer H, Carter JL, Eisenstein RB, Bayrakci C. A re-evaluation of the relationship between glucose-6-phosphate dehydrogenase deficiency and the behavioral manifestations of schizophrenia. J Lab Clin Med 1965; 65: 222-227.
50. Petrakis NL, Petrakis SJ, Wiesenfeld SL, Spanidou E. Possible incompatibility of glucose-6-phosphate dehydrogenase deficiency and championship athletic performance. Med Sci Sports Exerc 1974; 6: 191-192.
51. Chanmugam D, Frumin AM. Abnormal oral glucose tolerance response in erythrocyte glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1964; 271: 1202-1204.
52. Niazi GA. Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus. Int J Hematol 1991; 54: 295-298.
53. Eppes R, Brewer G, De Gowin R et al. Oral glucose tolerance in negro men deficient in G-6-PD. N Engl J Med 1966; 275: 855-861.
54. Monte Alegre S, Saad STO, Delatre E, Saad MJA. Insulin secretion in patients deficient in glucose-6-phosphate dehydrogenase. Horm Metab Res 1991; 23: 171-173.
55. Meloni T, Pacifico A, Forteleoni G, Meloni GF. G6PD deficiency and diabetes mellitus in northern Sardinian subjects. Haematologica 1992; 77: 94-95.
56. Sheriff DS, El Fakhri M. Serum lipoprotein profile and concentration of dehydroepiandrosterone sulfate (DHEAS) in glucose-6-phosphate dehydrogenase-deficient subjects. Clin Chem 1990; 36: 393-394.
57. Orlina AR, Josephson AM, McDonald BJ. The poststorage viability of glucose-6-phosphate dehydrogenase-deficient erythrocytes. J Lab Clin Med 1970; 75: 930-936.
58. McCurdy PR, Morse EE. Glucose-6-phosphate dehydrogenase deficiency and blood transfusion. Vox Sang 1975; 28: 230-237.
59. Shalev O, Manny N, Sharon R. Posttransfusional hemolysis in recipients of glucose-6-phosphate dehydrogenase-deficient erythrocytes. Vox Sang 1993; 64: 94-98.
60. Knox-Macaulay HHM. Glucose-6-phosphate dehydrogenase deficiency in blood donors. Saudi Med J 1987; 8: 325-326.
61. Kumar P, Sarkar S, Narang A. Acute intravascular haemolysis following exchange transfusion with G-6-PD deficient blood. Eur J Pediatr 1994; 153: 98-99.
62. Gulati S, Singh S, Narang A, Bhakoo ON. Exchange transfusion with G-6-PD deficient donor blood causes exaggeration of neonatal hyperbilirubinemia. Indian Pediatr 1989; 26: 499-501.
63. Mimouni F, Shohat S, Reisner SH. G6PD-deficiency donor blood as a cause of hemolysis in two preterm infants. Isr J Med Sci 1986; 22: 120-122.
64. Browne EA. The inheritance of an intrinsic abnormality of the red blood cell predisposing to drug-induced hemolytic anemia. Johns Hopkins Med J 1957; 101: 115-118.
65. Kalmus H. Distance and sequence of the loci for protan and deutan defects and for glucose-6-phosphate dehydrogenase deficiency. Nature 1962; 194: 214-215.
66. Beutler E. X-inactivation in heterozygous G-6-PD variant females In: Yoshida A, Beutler E, eds Glucose-6-Phosphate Dehydrogenase. Orlando, FL: Academic Press, 1986: 405-415.
67. Beutler E, Yoshida A. Genetic variation of glucose-6-phosphate dehydrogenase: a catalog and future prospects. Medicine (Baltimore) 1988; 67: 311-334.
68. Toniolo D, Persico MG, Battistuzzi G, Luzzatto L. Partial purification and characterization of the messenger RNA for human glucose-6-phosphate dehydrogenase. Mol Biol Med 1984; 2: 89-103.
69. Persico MG, Viglietto G, Martini G et al. Analysis of the primary structure of human G 6 PD deduced from the cDNA sequence. In: Yoshida A, Beutler E, eds. Glucose-6-Phosphate Dehydrogenase. Orlando, FL: Academic Press, 1986: 503-516.
70. Persico MG, Viglietto G, Martino G et al. Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region. Nucleic Acids Res 1986; 14: 2511-2522, 7822.
71. Takizawa T, Huang IY, Ikuta T, Yoshida A. Human glucose-6-phosphate dehydrogenase: primary structure and cDNA cloning. Proc Natl Acad Sci USA 1986; 83: 4157-4161.
72. Beutler E, Westwood B, Melemed A, Dal Borgo P, Margolis D. Three new exon 10 glucose-6-phosphate dehydrogenase mutations. Blood Cells Mol Dis 1995; 21: 64-72.
73. Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 1979; 300: 1001-1005.
74. Luzzatto L. Studies of polymorphic traits for the characterization of populations. African populations South of the Sahara. Isr J Med Sci 1973; 9: 1181-1194.
75. Kay AC, Kuhl W, Prchal JT, Beutler E. The origin of G6PD polymorphisms in Afro-Americans. Am J Hum Genet 1992; 50: 394-398.
76. 202A376G: Evidence for a single origin of the common G6PD A- mutation. Hum Genet 1990; 85: 9-11.
77. Vulliamy TJ, Othman A, Town M et al. Polymorphic sites in the African population detected by sequence analysis of the glucose-6-phosphate dehydrogenase gene outline the evolution of the variants A and A-. Proc Natl Acad Sci USA 1991; 88: 8568-8571.
78. Oppenheim A, Jury CL, Rund D, Vulliamy TJ, Luzzatto L. G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Genet 1993; 91: 293-294.
79. Beutler E, Westwood B, Kuhl W, Hsia YE. Glucose-6-phosphate dehydrogenase variants in Hawaii. Hum Hered 1992; 42: 327-329.
80. Ganczakowski M, Town M, Bowden DK et al. Multiple glucose-6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific). Am J Hum Genet 1995; 56: 294-301.
81. Vives Corrons JL, Rovira A, Pujades MA, Estrada M, Vulliamy TJ. Diverse point mutations of glucose-6-phosphate dehydrogenase (G6PD) gene in Spanish and Cuban patients with hemolytic anaemia. La Revista de Investigacion Clinica 1994; 46(Suppl): 234a.
82. Calabro V, Mason PJ, Filosa S et al. Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis. Am J Hum Genet 1993; 52: 527-536.
83. Beutler E, Prchal JT, Westwood B, Kuhl W. Definition of the mutations of G6PD Wayne, G6PD Viangchan, G6PD Jammu and G6PD 'LeJeune'. Acta Haematol (Basel) 1991; 86: 179-182.
84. Greene LS. G6PD deficiency as protection against falciparum malaria: an epidemiologic critique of population and experimental studies. Yearbook of Physical Anthropology 1993; 36 Suppl. 17: 153-178.
85. Luzzatto L, Usanga EA, Reddy S. Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Science 1969; 164: 839-842.
86. Golenser J, Miller J, Spira DT, Kosower IMS, Vande Waa JA, Jensen JB. Inhibition of the intraerythrocytic development of Plasmodium falciparum in glucose-6-phosphate dehydrogenase deficient erythrocytes is enhanced by oxidants and by crisis form factor. Trop Med Parasitol 1988; 39: 273-276.
87. Luzzatto L, O'Brien S, Usanga E, Wanachiwanawin W. Origin of G6PD polymorphism: Malaria and G6PD deficiency. In: Yoshida A, Beutler E, eds. Glucose-6-Phosphate Dehydrogenase. Orlando, FL: Academic Press 1986: 181-193.
88. Ruwende C, Khoo SC, Snow RW et al. Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376: 246-249.
89. Linder D, Gartler SM. Glucose-6-phosphate dehydrogenase mosaicism: utilization as cell marker in the study of leiomyomas. Science 1965; 150: 67-69.
90. Beutler E, Collins Z, Irwin LE. Value of genetic variants of glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors. N Engl J Med 1967; 276: 389-391.
91. Fialkow PJ. Clonal origin of human tumors. Biochim Biophys Acta 1976; 458: 283-321.
92. Oni SB, Osunkoya BO, Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood 1970; 36: 145-152.
93. Ferraris AM, Giuntini P, Galiano S, Gaetani GF. 2-Deoxyglucose-6-phosphate utilization in the study of glucose-6-phosphate dehydrogenase mosaicism. Am J Hum Genet 1981; 33: 307-313.
94. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238: 193-197.
95. Lindsay S, Monk M, Holiday R et al. Differences in methylation on the active and inactive human X chromosomes. Ann Hum Genet 1985; 49: 115-127.
96. Curnutte JT, Hopkins PJ, Kuhl W, Beutler E. Studying X-inactivation. Lancet 1992; 339: 749.
97. Luhovy M, Belickova M, Liu Y, Prchal JF, Prchal JT. A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55. Biol Bone Blood Marrow Transplant 1995; 2: 81-87.
98. Rajkondawar VL, Modi TH, Mishra SN. Drug induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency subjects. J Assoc Physicians (India) 1968; 16: 589-593.
99. Omar MES, Wahab MFA. Treatment of typhoid and paratyphoid fever with furazolidone. J Trop Med Hyg 1967; 70: 43-45.
100. Little C, Schacter B. Hemolytic anemia following isobutyl nitrate (IBN) inhalation in a patient with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Blood 1979; 54(Suppl.1): 34a.
101. Melzer-Lange M, Walsh-Kelly C. Naphthalene-induced hemolysis in a black female toddler deficient in glucose-6-phosphate dehydrogenase. Pediatr Emerg Care 1989; 5: 24-26.
102. Todisco V, Lamour J, Finberg L. Hemolysis from exposure to naphthalene mothballs. N Engl J Med 1991; 325: 1660.
103. Ducros J, Saingra S, Rampai M, Coulange C, Barbe M-C, Verzetti G. Hemolytic anemia due to G6PD deficiency and urate oxidase in a kidney-transplant patient. Clin Nephrol 1991; 35: 89-90.
104. Tishler M. Phenazopyridine-induced hemolytic anemia in a patient with G-6-PD deficiency. Acta Haematol (Basel) 1983; 70: 208-209.